Moderna Inc

NASDAQ:MRNA   3:59:59 PM EDT
148.42
-6.54 (-4.22%)
4:51:05 PM EDT: $148.87 +0.45 (+0.30%)
Regulatory, Other Pre-Announcement

Moderna Inc - Cash, Cash Equivalents And Investments As Of December 31, 2021, Were More Than $17 Billion

Published: 01/04/2022 14:52 GMT
Moderna Inc (MRNA) - Moderna Inc - Cash, Cash Equivalents and Investments As of December 31, 2021, Were More Than $17 Billion.
Moderna Inc - FDA Has Granted Priority Review Designation for Bla Filing of Covid-19 Vaccine.
Moderna Inc - by Year End, Co Shipped About 800 Million Doses of Covid-19 Vaccine Worldwide.
Moderna Inc - Top Priorities for 2022 Include Pan-respiratory Annual Single-dose Booster Vaccine.
Moderna Inc - Expect Investments Will Increase Global 2022 Capacity to Manufacture Enough Drug Substance for Up to 3 Billion Doses of Covid-19 Vaccine.
Moderna Inc - Anticipate Development Candidate for Covid Booster + Flu Booster in a Single Dose, Mrna-1073, Will Be in the Clinic Soon.
((reuters.
Briefs@thomsonreuters.
Com;)).